Meeder Advisory Services Inc. Has $1.95 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Meeder Advisory Services Inc. increased its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,795 shares of the company’s stock after buying an additional 226 shares during the period. Meeder Advisory Services Inc.’s holdings in Colgate-Palmolive were worth $1,951,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Edgestream Partners L.P. bought a new position in Colgate-Palmolive during the first quarter worth $1,571,000. Covestor Ltd lifted its position in shares of Colgate-Palmolive by 26.9% in the 1st quarter. Covestor Ltd now owns 1,015 shares of the company’s stock worth $91,000 after acquiring an additional 215 shares during the period. Bessemer Group Inc. increased its holdings in Colgate-Palmolive by 69.2% in the 1st quarter. Bessemer Group Inc. now owns 43,475 shares of the company’s stock valued at $3,915,000 after buying an additional 17,773 shares during the period. Lake Street Advisors Group LLC raised its stake in shares of Colgate-Palmolive by 38.8% in the 1st quarter. Lake Street Advisors Group LLC now owns 4,930 shares of the company’s stock valued at $444,000 after buying an additional 1,377 shares in the last quarter. Finally, Pitcairn Co. lifted its holdings in shares of Colgate-Palmolive by 11.2% during the 1st quarter. Pitcairn Co. now owns 7,904 shares of the company’s stock worth $712,000 after acquiring an additional 795 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 16.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. UBS Group upped their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $105.11.

View Our Latest Report on CL

Colgate-Palmolive Trading Up 1.2 %

CL opened at $94.65 on Tuesday. The firm has a market capitalization of $77.33 billion, a PE ratio of 27.12, a P/E/G ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The company’s 50-day moving average is $99.06 and its 200 day moving average is $98.55.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.